Literature DB >> 20027488

Effects of fluoxetine and imipramine in rat fetuses treated during a critical gestational period: a macro and microscopic study.

Cátia Aline Silva Swerts1, Ana Maria Duarte Dias Costa, Alessandra Esteves, Carla Elaine Silva Borato, Mário Sérgio Oliveira Swerts.   

Abstract

OBJECTIVE: To evaluate morphological alterations in rat fetuses treated with fluoxetine and imipramine during the "critical" period of gestation.
METHOD: Fifteen female rats were separated into three groups (n = 5) and treated with 10 mg/kg/day of test substances on the ninth, tenth and eleventh day of pregnancy: G1, fluoxetine; G2, imipramine hydrochloride; G3 (control), saline. On day 21, cesarean sections were performed to release the fetuses, whose bodies were weighed and macroscopically analyzed. The placenta was also weighed. The fetuses were then fixed and their encephala removed and weighed. Sections of the frontal lobe were taken for histological neuron counting.
RESULTS: G1 and G2 showed the highest fetal body weight. Placental weight showed statistical differences (p < 0.01): G1 weighed more than G2 and G3. Otherwise, G2 exhibited the highest encephalon weight, statistically differing from G3 (control) and fluoxetine-treated G1 (p < 0.01). However, G1 did not statistically (p > 0.01) differ from the control group. G3 showed the highest number of neurons per area when compared to G1 and G2 (p < 0.01).
CONCLUSION: The use of antidepressants in rats caused an increase in fetal weight and a decrease in the number of fetal frontal lobe neurons, thus suggesting that the use of antidepressants by pregnant women can induce depression in fetuses due to alterations in their neural development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20027488     DOI: 10.1590/s1516-44462009005000015

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  6 in total

1.  Forced swim test behavior in postpartum rats.

Authors:  R M Craft; M L Kostick; J A Rogers; C L White; K T Tsutsui
Journal:  Pharmacol Biochem Behav       Date:  2010-07-01       Impact factor: 3.533

Review 2.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

3.  Prenatal Venlafaxine Exposure-Induced Neurocytoarchitectural and Neuroapoptotic Degeneration in Striatum and Hippocampus of Developing Fetal Brain, Manifesting Long-term Neurocognitive Impairments in Rat Offspring.

Authors:  K P Singh; Prashant Sharma; Manish Singh
Journal:  Neurotox Res       Date:  2022-07-12       Impact factor: 3.978

4.  Neurobehavioral manifestations of developmental impairment of the brain.

Authors:  Michal Dubovický
Journal:  Interdiscip Toxicol       Date:  2010-06

5.  The expression of HoxB5 and SPC in neonatal rat lung after exposure to fluoxetine.

Authors:  Razieh Taghizadeh; Zahra Taghipour; Akbar Karimi; Ali Shamsizadeh; Mohammad Mohsen Taghavi; Mahdi Shariati; Ahmad Shabanizadeh; Hamid Reza Jafari Naveh; Reza Bidaki; Fariba Aminzadeh
Journal:  Drug Des Devel Ther       Date:  2016-11-02       Impact factor: 4.162

6.  Neuronal differentiation pathways and compound-induced developmental neurotoxicity in the human neural progenitor cell test (hNPT) revealed by RNA-seq.

Authors:  Victoria C de Leeuw; Conny T M van Oostrom; Paul F K Wackers; Jeroen L A Pennings; Hennie M Hodemaekers; Aldert H Piersma; Ellen V S Hessel
Journal:  Chemosphere       Date:  2022-06-11       Impact factor: 8.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.